Polymyositis Clinical Trials

59 clinical trials for Polymyositis across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Tübingen registry for autologous stem cell transplantation for severe autoimmune diseases — RECRUITING
• Adult and Juvenile Myositis — RECRUITING
• A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy — RECRUITING · PHASE3
• Environmental Risk Factors for the Anti-synthetase Syndrome — RECRUITING
• A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies — RECRUITING · PHASE3
• Rheumatology Patient Registry and Biorepository — RECRUITING
• MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) — RECRUITING
• CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease — RECRUITING · PHASE1
• Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases — RECRUITING · PHASE1
• Diagnostic relevance and limitations of myosonography in patients with idiopathic inflammatory myopathy — RECRUITING
• Myalgias in myopathies: severity, consequences and type of muscle pain — RECRUITING
• A MULTICENTER, PARALLEL-GROUP, DOUBLE-BLIND, 2-ARM, PHASE III STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ANIFROLUMAB ADMINISTERED AS SUBCUTANEOUS INJECTION AND ADDED TO STANDARD OF CARE COMPARED WITH PLACEBO ADDED TO STANDARD OF CARE IN ADULT PARTICIPANTS WITH POLYMYOSITIS (JASMINE) — RECRUITING · PHASE3
• Study of efficacy and tolerability for BAF312 compared to placebo in patients with polymyositis — COMPLETED · PHASE2
• Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases — COMPLETED
• A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. — COMPLETED · PHASE2
• Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies — COMPLETED · NA
• Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties — COMPLETED · NA
• Add-on Intravenous Immunoglobulins in Early Myositis — ACTIVE_NOT_RECRUITING · PHASE2
• Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis — COMPLETED · PHASE2
• A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis — COMPLETED · PHASE2
• Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM. — COMPLETED · PHASE2
• Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis — NOT_YET_RECRUITING · PHASE2
• Study of M5049 in DM and PM Participants (NEPTUNIA) — TERMINATED · PHASE2
• A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments — TERMINATED · PHASE3
• Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM) — COMPLETED · PHASE1
• A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis — COMPLETED · PHASE1
• Study and Treatment of Inflammatory Muscle Diseases — COMPLETED
• High-intensity Strength Training in Myositis — COMPLETED · NA
• Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis — COMPLETED · PHASE1
• PatientSpot Formerly Known as ArthritisPower — OTHER
• Testing the sensitivity and specificity of EUROLINE immunoblots for systemic sclerosis and autoimmune muscle diseases — OTHER
• Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy — COMPLETED · PHASE3
• Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy — OTHER · PHASE2
• Plexin D1 as a Potential Biomarker inPM/DM — OTHER
• Predictor of Clinical Response to Acthar in Myositis — COMPLETED
• Efficacy and Tolerability of BAF312 in Patients With Polymyositis — TERMINATED · PHASE2
• Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity — COMPLETED
• Abatacept Treatment in Polymyositis and Dermatomyositis — COMPLETED · PHASE2
• Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis — COMPLETED · PHASE2
• Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus — COMPLETED · PHASE2
• Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis — COMPLETED · PHASE2
• Epidemiological Study of Inflammatory Myopathies in a French Region — COMPLETED
• Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis — TERMINATED · PHASE2
• Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and Dermatomyositis — OTHER · NA
• Acthar in Treatment of Refractory Dermatomyositis and Polymyositis — COMPLETED · PHASE2
• Study of the Prevalence of Polymyositis and Dermatomyositis in Normandy — COMPLETED
• Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM — COMPLETED · PHASE3
• Dermatomyositis and Polymyositis Registry — OTHER
• Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) — COMPLETED · PHASE2
• Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM) — COMPLETED · PHASE3

Refine this search